Literature DB >> 31186837

A brief history of the treatment of viral hepatitis C.

Doris B Strader1, Leonard B Seeff2,3.   

Abstract

Entities:  

Year:  2012        PMID: 31186837      PMCID: PMC6490695          DOI: 10.1002/cld.1

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN: 2046-2484


× No keyword cloud information.
  74 in total

1.  Peginterferon alfa-2a in patients with chronic hepatitis C.

Authors:  S Zeuzem; S V Feinman; J Rasenack; E J Heathcote; M Y Lai; E Gane; J O'Grady; J Reichen; M Diago; A Lin; J Hoffman; M J Brunda
Journal:  N Engl J Med       Date:  2000-12-07       Impact factor: 91.245

2.  A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C.

Authors:  K L Lindsay; C Trepo; T Heintges; M L Shiffman; S C Gordon; J C Hoefs; E R Schiff; Z D Goodman; M Laughlin; R Yao; J K Albrecht
Journal:  Hepatology       Date:  2001-08       Impact factor: 17.425

Review 3.  Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease.

Authors:  R P Perrillo
Journal:  Gastroenterology       Date:  2001-03       Impact factor: 22.682

4.  Viral kinetics in genotype 1 chronic hepatitis C patients during therapy with 2 different doses of peginterferon alfa-2b plus ribavirin.

Authors:  Maria Buti; Francisco Sanchez-Avila; Yoav Lurie; Carlos Stalgis; Auristela Valdés; Maria Martell; Rafael Esteban
Journal:  Hepatology       Date:  2002-04       Impact factor: 17.425

5.  Interferon-alpha and ribavirin treatment of hepatitis C in children with malignancy in remission.

Authors:  B Christensson; T Wiebe; A Akesson; A Widell
Journal:  Clin Infect Dis       Date:  2000-03       Impact factor: 9.079

6.  Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.

Authors:  M P Manns; J G McHutchison; S C Gordon; V K Rustgi; M Shiffman; R Reindollar; Z D Goodman; K Koury; M Ling; J K Albrecht
Journal:  Lancet       Date:  2001-09-22       Impact factor: 79.321

7.  A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation.

Authors:  Jeffrey S Crippin; Tim McCashland; Norah Terrault; Patricia Sheiner; Michael R Charlton
Journal:  Liver Transpl       Date:  2002-04       Impact factor: 5.799

8.  Efficacy and safety of pegylated (40-kd) interferon alpha-2a compared with interferon alpha-2a in noncirrhotic patients with chronic hepatitis C.

Authors:  K R Reddy; T L Wright; P J Pockros; M Shiffman; G Everson; R Reindollar; M W Fried; P P Purdum; D Jensen; C Smith; W M Lee; T D Boyer; A Lin; S Pedder; J DePamphilis
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

9.  Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.

Authors:  Michael W Fried; Mitchell L Shiffman; K Rajender Reddy; Coleman Smith; George Marinos; Fernando L Gonçales; Dieter Häussinger; Moises Diago; Giampiero Carosi; Daniel Dhumeaux; Antonio Craxi; Amy Lin; Joseph Hoffman; Jian Yu
Journal:  N Engl J Med       Date:  2002-09-26       Impact factor: 91.245

10.  Recombinant alfa-interferon plus ribavirin therapy in children and adolescents with chronic hepatitis C.

Authors:  Stefan Wirth; Thomas Lang; Stephan Gehring; Patrick Gerner
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

View more
  4 in total

Review 1.  Safety of direct acting antiviral treatment for hepatitis C in oncologic setting: A clinical experience and a literature review.

Authors:  Anna Maria Spera
Journal:  World J Hepatol       Date:  2022-03-27

2.  Success of Direct-Acting, Antiviral-Based Therapy for Chronic Hepatitis C Is Not Affected by Type 2 Diabetes.

Authors:  Blake A Niccum; Jonathan G Stine; Javelle A Wynter; Virginia Kelly; Stephen H Caldwell; Neeral L Shah
Journal:  Clin Diabetes       Date:  2020-01

Review 3.  Hepatitis C Positive Organ Donation in Heart Transplantation.

Authors:  Hasan K Siddiqi; Kelly H Schlendorf
Journal:  Curr Transplant Rep       Date:  2021-11-10

Review 4.  HIV, HCV and HBV: A Review of Parallels and Differences.

Authors:  Maria C Leoni; Andrew Ustianowski; Hamzah Farooq; Joop E Arends
Journal:  Infect Dis Ther       Date:  2018-09-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.